Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
European Journal of Medicinal Chemistry|May 15, 2007
Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cellsHari N Pati, Umashankar Das, J Wilson Quail, et al.Inorganic Chemistry|August 6, 2002
Synthesis and characterization of iron complexes with monoanionic and dianionic N,N',N' '-trialkylguanidinate ligandsStephen R Foley, Glenn P A Yap, Darrin S RichesonEuropean Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 26, 2012
Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanomaDeborah Michel, Jackson M Chitanda, Réka Balogh, et al.Inorganic Chemistry|June 7, 2008
Synthesis and characterization of aluminum- and gallium-bridged [1.1]chromarenophanes and [1.1]molybdarenophanesClinton L Lund, Jörg A Schachner, Ian J Burgess, et al.Journal of the American Chemical Society|February 11, 2005
Acrylonitrile insertion reactions of cationic palladium alkyl complexesFan Wu, Stephen R Foley, Christopher T Burns, et al.Journal of the American Chemical Society|April 3, 2003
Reaction of vinyl chloride with late transition metal olefin polymerization catalystsStephen R Foley, Robert A Stockland, Han Shen, et al.Dalton Transactions (Cambridge, England : 2003)|January 7, 2011
Oxazoles revisited: On the nature of binding of benzoxazole and 2-methylbenzoxazole with the zinc and palladium halidesRoderick C Jones, Maja W Chojnacka, J Wilson Quail, et al.Journal of Clinical Apheresis|August 1, 2016
How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice surveyChristopher J Patriquin, William F Clark, Katerina Pavenski, et al.Organic & Biomolecular Chemistry|March 25, 2006
Synthesis and biological activity of tetralone abscisic acid analoguesJames M Nyangulu, Ken M Nelson, Patricia A Rose, et al.Kidney International. Supplement|January 31, 2009
A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpuraStephen R Foley, Kathryn Webert, Donald M Arnold, et al.Pageof 5